Aldatu Biosciences: Funding, Investors & Team (Sep 2026)
Aldatu Biosciences is a Boston, MA-based, early-stage biotechnology company developing innovative diagnostic tools based on its proprietary genotyping platform, PANDAA. Aldatu is committed to commercializing products that address diagnostic challenges in global health, primarily in HIV and other infectious diseases, and which improve both the quality of patient care and healthcare cost-efficiency.
Aldatu Biosciences has raised $3.0M across 1 funding round on record, the most recent a Grant of $3.0M announced in Sep 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aldatu Biosciences Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Aldatu Biosciences Funding Rounds
Aldatu Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Aldatu Biosciences Funding Compared to Other Biotechnology Startups
Aldatu Biosciences' latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aldatu Biosciences in Biotechnology and Boston
Companies Similar to Aldatu Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Aldatu Biosciences Funding FAQs
What does Aldatu Biosciences do?
Aldatu Biosciences is a Boston, MA-based, early-stage biotechnology company developing innovative diagnostic tools based on its proprietary genotyping platform, PANDAA. Aldatu is committed to commercializing products that address diagnostic challenges in global health, primarily in HIV and other infectious diseases, and which improve both the quality of patient care and healthcare cost-efficiency.
How much funding has Aldatu Biosciences raised?
Aldatu Biosciences has raised $3.0M across 1 round on record. The most recent is a Grant of $3.0M announced in Sep 2022.
When did Aldatu Biosciences last raise funding?
Aldatu Biosciences' most recent funding round on record is a Grant of $3.0M, announced in Sep 2022.
Who founded Aldatu Biosciences?
FundedIQ lists David Raiser (Founder) at Aldatu Biosciences.
Where is Aldatu Biosciences headquartered?
Aldatu Biosciences is based in Boston, Massachusetts, United States.
How many employees does Aldatu Biosciences have?
Aldatu Biosciences is in the 1-10 employee band.
How does Aldatu Biosciences' funding compare to other Biotechnology startups?
Aldatu Biosciences' latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Aldatu Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aldatu Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.